Living with Hashimoto Thyroiditis: Diagnosis, Treatment and Lifestyle

Hashimoto thyroiditis is an autoimmune disease in which T lymphocytes mount a chronic attack on thyroid follicular cells. B lymphocytes produce antibodies against thyroid antigens (thyroid peroxidase, thyroglobulin). The thyroid parenchyma is gradually replaced by lymphocytic infiltrate and fibrous tissue.

Genetic predisposition is strong — HLA-DR3 and HLA-DR5 haplotypes are common in individuals with a positive family history. Additional triggers include iodine excess, the postpartum period, viral infections, stress and smoking. Thyroid autoimmunity rarely occurs alone; it can coexist with vitiligo, coeliac disease, type 1 diabetes, Addison disease and other autoimmune conditions.

There is a clear female predominance — F/M ratio of 7-10:1. Age at diagnosis is most often between 30 and 50. Anti-TPO positivity is found in 10-15% of the general population, but not all progress to overt disease. Progression from subclinical to overt hypothyroidism typically takes 5-10 years. We expand on the clinical framework in our thyroid surgery programme.

Early Hashimoto has no symptoms. Thyroid function is normal, but anti-TPO antibodies are positive — the "euthyroid Hashimoto" phase. Most patients are diagnosed incidentally during testing for another reason.

In the subclinical hypothyroid phase, TSH is mildly elevated (4.0-10.0 mIU/L) with normal free T4. Symptoms may be mild or absent — fatigue, cold intolerance, weight tendency, mild concentration difficulty. Whether to start treatment in this phase is an individualised decision.

In overt hypothyroidism, TSH is clearly high (>10 mIU/L) and free T4 is low. Symptoms become clear: fatigue, weight gain, dry skin, hair thinning or loss, constipation, muscle and joint aches, depressed mood, menstrual irregularity in women, hoarse voice. Treatment is mandatory.

Transient thyrotoxicosis (Hashitoxicosis) can occur — release of stored hormone from destruction. It lasts a few weeks to months and resolves spontaneously, after which permanent hypothyroidism sets in.

First-line tests are TSH and free T4. An elevated TSH points to incipient thyroid failure. To confirm Hashimoto as the aetiology, anti-TPO antibodies are requested. Anti-TPO is positive in over 90% of cases. Anti-thyroglobulin is a supportive secondary marker.

Thyroid ultrasound contributes to diagnosis. In Hashimoto, the gland appears heterogeneous and hypoechoic, with a "pseudo-nodular" pattern and reduced vascularity. Ultrasound also screens for true nodules — the relationship between Hashimoto and papillary thyroid cancer, particularly lymphoma, makes follow-up important.

Clinical follow-up nuances: in pregnancy, the upper TSH limit is lowered (2.5 in first trimester, 3.0 thereafter); symptomatic subclinical hypothyroidism may justify treatment; in older patients the TSH upper limit is somewhat looser (4.5-5.5). These nuances require individualised clinical judgement.

Levothyroxine (L-T4) directly replaces the missing thyroxine. In a young, otherwise-healthy adult the starting dose is about 1.5-1.7 mcg/kg/day; in older patients or with cardiac disease, start low (25-50 mcg) with slow titration. Take the tablet on an empty stomach in the morning; wait 30-60 minutes before breakfast.

Iron, calcium, magnesium, antacids, omeprazole and certain dietary fibres reduce levothyroxine absorption — separate these from L-T4 by at least 4 hours. Even coffee can reduce absorption, so a 30-minute wait after the dose is a practical rule. Some patients prefer bedtime dosing 3-4 hours fasting — also acceptable.

Re-check TSH 6-8 weeks after any dose change (equilibrium time). In stable patients, 1-2 checks per year suffice. Pregnancy, menopause, significant weight change and new medications may all require dose review. Self-titration is not advised — laboratory monitoring is essential. Step-by-step details: Hashimoto page.

Selenium: 200 mcg/day of selenomethionine modestly reduces anti-TPO levels in Hashimoto, but clinical benefit (TSH normalisation, symptom score) is debated. One or two Brazil nuts per day is a natural source. Chronic high doses are not recommended because selenium is neurotoxic in excess.

Iodine: in Hashimoto, excess iodine is harmful — it can accelerate gland destruction. Iodised salt used in Türkiye and the iodine in a balanced diet are safe; high-dose iodine supplements or megavitamin preparations are not advised. In pregnancy use a standard prenatal vitamin containing 150 mcg iodine.

Gluten: coeliac disease and coeliac sensitivity are 5-10 times more common in Hashimoto. Coeliac screening (anti-tissue transglutaminase) is a sensible step. With confirmed coeliac, a gluten-free diet is mandatory. In coeliac-negative Hashimoto patients, evidence that gluten restriction lowers antibodies is weak — routine gluten avoidance is not recommended.

Most other popular advice (vitamin D only if deficient, zinc, ashwagandha, etc.) can be supportive, but does not treat Hashimoto itself. The evidence base is weak; levothyroxine remains the core therapy. Be cautious about expensive "Hashimoto protocols".

Thyroid hormone requirement rises 30-50% in pregnancy. A Hashimoto patient on levothyroxine should increase her dose by about 25-30% as soon as pregnancy is confirmed. Plan ahead — patients can be told to add 2 extra doses per week as soon as they have a positive test, before they reach their physician.

Trimester-specific TSH targets: ≤2.5 mIU/L in the first, ≤3.0 mIU/L in the second and third. Maternal hypothyroidism is critical for fetal brain development; TSH should be normalised pre-conception. Monitor TSH every 4 weeks.

The postpartum period requires careful surveillance. Postpartum thyroiditis (more frequent in Hashimoto) presents 3-6 months after delivery with a thyrotoxic phase followed by a hypothyroid phase. Gland function normalises within 1 year in most cases, but Hashimoto-positive women have a 30-50% risk of permanent hypothyroidism.

Hashimoto flags an individual with risk for autoimmune polyglandular syndrome. Common associations: vitiligo, coeliac disease, type 1 diabetes, pernicious anaemia, rheumatoid arthritis, Sjögren syndrome, Addison disease. Awareness aids early diagnosis.

Vitamin B12 deficiency is more common because of associated autoimmune gastritis / pernicious anaemia. Annual B12 testing is reasonable. Iron-deficiency anaemia can coexist in women with menstrual irregularity; monitor and treat orally or parenterally as needed.

Thyroid lymphoma risk, although small, is meaningfully increased in Hashimoto. A rapidly enlarging thyroid mass, pain or compressive symptoms require urgent evaluation — ultrasound and, where indicated, needle biopsy. The condition is rare but vigilance matters. We share patient experiences on our Istanbul thyroid surgery page.